Becton Dickinson and Company Common Stock (BDX)

About BDX

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peri…

Sector

Health Care

Industry

Medical/Dental Instruments

Employees

72,000

Website

www.bd.com/

Fundamentals

1-day range

$181.52$187.92

Market cap

$48.79B

P/E (trailing)

53.21

P/E (forward)

14.07

EPS (trailing)

$3.31

Dividend yield

1.59%

Beta

0.22

Avg. volume

2.28M

Ex-dividend date

September 9, 2026

Dividend pay date

September 30, 2026

Forecasts

12 analyst ratings

Becton Dickinson and Company Common Stock Competitors

Chosen by industry and closest market cap.

• BDX

  Becton Dickinson and Company Common Stock

  $189.6

  ▲ 0.78%
  Market cap $48.79BP/E 53.21
  $127.59$193.07
• MDLN

  Medline Inc. Class A Common Stock

  $35.29

  ▲ 1.85%
  Market cap $45.34BP/E 67.50
  $32.49$50.88
• RMD

  ResMed Inc. Common Stock

  $240.24

  ▲ 1.90%
  Market cap $32.38BP/E 21.47
  $180.27$284.87
• DXCM

  DexCom Inc. Common Stock

  $90.8

  ▲ 1.69%
  Market cap $31.33BP/E 34.53
  $54.11$92.59
• BSX

  Boston Scientific Corporation Common Stock

  $46.83

  ▲ 0.34%
  Market cap $71.45BP/E 20.40
  $42.2$109.5
• BAX

  Baxter International Inc. Common Stock

  $26.12

  ▲ 0.77%
  Market cap $13.96BP/E —
  $15.73$30
• GMED

  Globus Medical Inc. Class A Common Stock

  $83.06

  ▲ 0.63%
  Market cap $11.01BP/E 21.55
  $54.15$101.4

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Becton Dickinson (BDX) Could Be 1% Overvalued As PREVENT Trial Enrollment Ends
  Yahoo · 8/22/2026
• Becton Dickinson (BDX) Stock Could Be A Bargain On Cash Flow But Full On Broader Checks
  Yahoo · 8/21/2026
• Becton Dickinson (BDX) Completes PREVENT Trial Enrollment For Hernia Prevention Mesh
  Yahoo · 8/21/2026
• BDX Completes PREVENT Trial Enrollment for Phasix Mesh Study
  Yahoo · 8/20/2026
• Can IART's SurgiMend Relaunch Help Drive a Broader 2027 Recovery?
  Yahoo · 8/20/2026
• What's Going On With Becton Dickinson Stock Wednesday?
  Benzinga · 8/19/2026
• FDA Issues Early Alert For High-Risk Issue With Becton Dickinson Convenience Kits; Becton Dickinson Advises Removal Of Recalled Components From Convenience Kits; Warns Against Use Of Sodium Chloride Ampules In Affected Bd Kits
  Benzinga · 8/18/2026
• BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire
  Yahoo · 8/17/2026

• Thomas E. Polen Jr. · August 13, 2026 · Option Exercise

  43.3K @ $167.25
• Thomas E. Polen Jr. · August 13, 2026 · Sale

  4.2K @ $185
• Thomas E. Polen Jr. · August 13, 2026 · Disposition

  39.1K @ $185
• Roland Goette · August 11, 2026 · Sale

  2.4K @ $180.84
• Robert Luther Huffines · August 6, 2026 · Grant

  189 @ $165.62
• Carrie L. Byington · August 6, 2026 · Grant

  94 @ $165.62
• Michael Feld · July 27, 2026 · Sale

  75 @ $157.13
• Bilal Muhsin · July 2, 2026 · Tax Withholding

  1.9K
• Bilal Muhsin · July 1, 2026 · Grant

  14.3K
• Michael Feld · June 26, 2026 · Sale

  75 @ $152.8
• Michael David Garrison · June 24, 2026 · Sale

  1.1K @ $145.66
• Michael David Garrison · June 10, 2026 · Sale

  1.1K @ $151.48
• Thomas E. Polen Jr. · June 1, 2026 · Option Exercise

  20.2K @ $126.16
• Thomas E. Polen Jr. · June 1, 2026 · Sale

  2.8K @ $146.35
• Thomas E. Polen Jr. · June 1, 2026 · Disposition

  17.4K @ $146.15

Institutional Ownership

March 31, 2026

Total shares held

241.36M

Total value held

$35.68B

Institutional holders

1454